FDA product code PBQ: Fixation, Non-Absorbable Or Absorbable, For Pelvic Use
PBQ is the FDA product code for fixation, non-absorbable or absorbable, for pelvic use. It is a Class II device, regulated under 21 CFR 884.4530 and reviewed by the Obstetrics and Gynecology panel. FDA has cleared 8 510(k) submissions under PBQ, 4 in the last five years, from 7 different applicants. The average 510(k) review took 128 days (median 126); 27 days on average over the last three years. FDA has posted 1 recall for PBQ devices, 1 initiated in the last five years.
Definition
Attaching suture or stapling ligaments of the pelvic floor.
Classification
| Field | Value |
|---|---|
| Device name | Fixation, Non-Absorbable Or Absorbable, For Pelvic Use |
| Device class | Class II |
| Regulation | 21 CFR 884.4530 |
| Review panel | OB — Obstetrics and Gynecology |
| Medical specialty | Obstetrics/Gynecology |
| Premarket route | 510(k) |
| Implant | Yes |
510(k) clearances per year for PBQ
| Year | Clearances | Avg. review days |
|---|---|---|
| 2022 | 2 | 120 |
| 2023 | 1 | 131 |
| 2026 | 1 | 27 |
Compare with all 510(k) review times · Search every PBQ clearance
Top PBQ applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Escala Medical | 2 | 2023-07-25 |
| Escala Medical, Ltd. | 1 | 2026-03-04 |
| Coloplast A/S | 1 | 2022-06-10 |
| Pop Medical Solutions | 1 | 2016-07-06 |
| Ibi Israel Biomedical Innovations , Ltd. | 1 | 2013-07-29 |
2 more applicants have PBQ clearances. See the full list in Caduvo.
Most recent PBQ clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260380 | Escala Medical, Ltd. | Mendit | 2026-03-04 | 27 |
| K230730 | Escala Medical | Apyx | 2023-07-25 | 131 |
| K220420 | Coloplast A/S | Saffron Fixation System | 2022-06-10 | 116 |
| K213783 | Escala Medical | Apyx | 2022-04-05 | 123 |
| K160569 | Pop Medical Solutions | NeuGuide | 2016-07-06 | 128 |
Recalls for PBQ devices
1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2021-12-13.
| Year | Recalls |
|---|---|
| 2021 | 1 |
HCPCS codes with matching descriptors
Text match between the FDA device name and CMS descriptors, not an official crosswalk:
- J0881 — Injection, darbepoetin alfa, 1 microgram (non-esrd use)
- J0888 — Injection, epoetin beta, 1 microgram, (for non esrd use)
Frequently asked questions
What is FDA product code PBQ?
PBQ is the FDA product code for fixation, non-absorbable or absorbable, for pelvic use. It is a Class II device, regulated under 21 CFR 884.4530 and reviewed by the Obstetrics and Gynecology panel.
What device class is PBQ?
Class II, regulation 21 CFR 884.4530. Typical premarket route: 510(k).
How long does a 510(k) take for product code PBQ?
Across 8 cleared submissions the average was 128 days from receipt to decision (median 126).
Which companies have the most PBQ clearances?
Escala Medical (2); Escala Medical, Ltd. (1); Coloplast A/S (1); Pop Medical Solutions (1); Ibi Israel Biomedical Innovations , Ltd. (1).
Have PBQ devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2021-12-13.
Next steps
- Run an FDA pathway report with predicate devices for product code PBQ
- Run a recall and safety report across every PBQ manufacturer
- Watch product code PBQ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Obstetrics and Gynecology product codes · FDA product code lookup · 510(k) database search · 510(k) review times